# NIOSH Hazard Review: Carbonless Copy Paper/Tables and Figures

Tables :
| 2—1 | CF coating slurry formulation | 7 |
| 3—1 | Exposures from CCP handling | 14 |
| 3—2 | Solvent emissions from CCP with intact microcapsules and 1% crushed microcapsules (mg/m$^2$ per hour) | 17 |
| 3—3 | Airborne concentrations of total dust and solvents produced with standardized paper handling in the laboratory (mg/m$^3$) | 18 |
| 3—4 | GC/MS analysis of CCP samples, SurSol 290 solvent, and area air samples (ppb) | 20 |
| 3—5 | Formaldehyde concentration after repeated turning of CCP sheets in a test chamber | 22 |
| 3—6 | Formaldehyde concentrations in the test chamber at various points after turning (total of 60 sheets for each condition) | 23 |
| 3—7 | Formaldehyde concentrations in the test chamber during a 90-min period | 23 |
| 3—8 | Formaldehyde concentrations in a test chamber containing eight CCP products | 24 |
| 3—9 | Effect of ventilation on formaldehyde concentrations in test chambers containing CCP | 26 |
| 3—10 | Summary of formaldehyde concentrations reported in CCP studies | 26 |
| 4—1 | Published case reports, case series, and health hazard evaluations involving exposure to CCP or CCP components | 31 |
| 4—2 | Summary of health-related inquiries from customers to Appleton Papers, Inc., May 1976 to December 1986 | 47 |
| 4—3 | Summary of cross-sectional studies that used questionnaires to assess the health effects of indoor air contaminants in general or CCP specifically | 49 |
| 4—4 | Job or workspace factors associated with the prevalence of work-related symptoms after adjustment for other personal, psychological, job, workspace, ​and building factors in northern California office workers, June—September 1990 | 59 |
| 4—5 | Types and locations of skin and mucous membrane symptoms in a Swedish questionnaire study | 62 |
| 4—6 | Dose-response relationship of CCP handling frequency with symptoms reported by respondents | 64 |
| 4—7 | Frequency of respiratory tract symptoms by type of paper and exposure level | 65 |
| 4—8 | Positive findings from physician interviews of 53 respondents to a health questionnaire | 67 |
| 4—9 | Dose-response relationship between CCP handling and mucous membrane and skin symptoms in two form-printing shops | 68 |
| 4—10 | Incidence of symptoms in exposed workers and their matched comparison workers during two exposure periods | 69 |
| 4—11 | Experimental laboratory investigations of allergic and irritative reactions in humans exposed to CCP | 72 |
| 4—12 | Analysis of repeated insult patch test (RIPT) studies submitted by industry clients in response to 1987 and 1997 Federal Register notices on CCP and its components | 76 |
| 4—13 | Frequency of occurrence and animal irritation category for chemicals identified in 12 French CCPs | 100 |
| 5—1 | Summary of studies that examined exposure-response relationships between CCP handling and irritative symptoms of the skin, eyes, or upper respiratory tract | 108 |
| 5—2 | Elevated ORs for CCP exposure and irritation of the skin, eyes, nose, or respiratory system reported in the indoor air cross-sectional studies | 109 |
Figures :
| 2—1 | Three-part carbonless copy paper system | 6 |
| 4—1 | Production of CCP and number of inquiries per year for all U.S. manufacturers from 1987 to 1996 | 48 |
| 4—2 | Prevalence of pruritus among CCP handlers by sheets of CCP handled during the exposure period | 70 |